FDA.reportPublic FDA data

NDC 68180-702 - Pioglitazone

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
68180-702
Package NDCs from labels
68180-702-11, 68180-702-13, 68180-702-06, 68180-702-09, 68180-702-02, 68180-702-03
Manufacturer
Lupin Pharmaceuticals, Inc. | LUPIN LIMITED
Effective date
2020-12-18
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Pioglitazone - Lupin Pharmaceuticals, Inc. | LUPIN LIMITEDLupin Pharmaceuticals, Inc. | LUPIN LIMITED2020-12-18HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDCRelated label
68180-702-02These highlights do not include all the information needed to use Pioglitazone Tablets USP safely and effectively. See full prescribing information for Pioglitazone Tablets USP. PIOGLITAZONE Tablets USP, 15 mg, 30 mg and 45 mg for oral use Initial U.S. Approval: 1999
68180-702-03These highlights do not include all the information needed to use Pioglitazone Tablets USP safely and effectively. See full prescribing information for Pioglitazone Tablets USP. PIOGLITAZONE Tablets USP, 15 mg, 30 mg and 45 mg for oral use Initial U.S. Approval: 1999
68180-702-06These highlights do not include all the information needed to use Pioglitazone Tablets USP safely and effectively. See full prescribing information for Pioglitazone Tablets USP. PIOGLITAZONE Tablets USP, 15 mg, 30 mg and 45 mg for oral use Initial U.S. Approval: 1999
68180-702-09These highlights do not include all the information needed to use Pioglitazone Tablets USP safely and effectively. See full prescribing information for Pioglitazone Tablets USP. PIOGLITAZONE Tablets USP, 15 mg, 30 mg and 45 mg for oral use Initial U.S. Approval: 1999
68180-702-13These highlights do not include all the information needed to use Pioglitazone Tablets USP safely and effectively. See full prescribing information for Pioglitazone Tablets USP. PIOGLITAZONE Tablets USP, 15 mg, 30 mg and 45 mg for oral use Initial U.S. Approval: 1999

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68180-702-02Pioglitazone500 in 1 BOTTLETABLET5009
68180-702-03Pioglitazone1000 in 1 BOTTLETABLET10009
68180-702-06Pioglitazone30 in 1 BOTTLETABLET309
68180-702-09Pioglitazone90 in 1 BOTTLETABLET909
68180-702-11Pioglitazone10 in 1 BLISTER PACKTABLET109
68180-702-13Pioglitazone10 in 1 CARTONTABLET109

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68180-702PIOGLITAZONE TABLET [LUPIN PHARMACEUTICALS, INC.]96 package rows20240101_d1f16bad-a40f-4653-b0f1-c40dca4785c5.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 3 · 54 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PioglitazonePIOGLITAZONENuCare Pharmaceuticals,Inc.a1112e4b-e9d5-13c3-e053-2995a90a6d0a2024-06-20Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 312440
unii: JQT35NPK6C
PioglitazonePIOGLITAZONENuCare Pharmaceuticals,Inc.a0846e3e-68b2-fd55-e053-2995a90a673e2024-06-20Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 317573
unii: JQT35NPK6C
PioglitazonePIOGLITAZONENuCare Pharmaceuticals,Inc.8d5ac747-991f-30e4-e053-2a95a90a47802024-06-18Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 312440
unii: JQT35NPK6C
PioglitazonePIOGLITAZONEProficient Rx LPf725cdaf-fc7a-40d6-ba64-1dccd1b25d7a2024-06-01Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 312440
unii: JQT35NPK6C
PioglitazonePIOGLITAZONEA-S Medication Solutions9fe57786-5c7d-4b11-8fb4-de341e2e51282023-12-05Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 312440
unii: JQT35NPK6C
PioglitazonePIOGLITAZONEA-S Medication Solutions4b5506c4-8cc2-44fb-ba2b-0e29fb73943d2023-12-05Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 312440
unii: JQT35NPK6C
PioglitazonePIOGLITAZONEA-S Medication Solutions475c4f39-dd2a-48f9-a07c-9344bbda58a92023-04-04Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 312441
unii: JQT35NPK6C
PioglitazonePIOGLITAZONEA-S Medication Solutions5f844e44-0f0d-4b28-9d34-b97780e1c6ec2023-02-06Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 317573
unii: JQT35NPK6C
PioglitazonePIOGLITAZONEMacleods Pharmaceuticals Limited482cef76-0623-4b4f-a0ea-f008c97b22812022-12-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 312441
rxcui: 312440
rxcui: 317573
unii: JQT35NPK6C
PioglitazonePIOGLITAZONENorthStar RxLLC692e662a-3b31-42c3-a075-42abe44c74db2022-09-08Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 312441
rxcui: 312440
rxcui: 317573
unii: JQT35NPK6C
PioglitazonePIOGLITAZONETeva Pharmaceuticals USA, Inc.c5c81c67-90cf-4e64-acb5-58b0358fa7422021-07-01Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 312441
rxcui: 312440
rxcui: 317573
unii: JQT35NPK6C
74261985-2ebd-47a2-86bb-44ee8944b058d1f16bad-a40f-4653-b0f1-c40dca4785c52020-12-18Boxed warning, Warnings, Adverse reactionsExact identifier
spl id: 74261985-2ebd-47a2-86bb-44ee8944b058
spl set id: d1f16bad-a40f-4653-b0f1-c40dca4785c5
PioglitazonePIOGLITAZONEAphena Pharma Solutions - Tennessee, LLCf434ba0d-13f3-42ae-a2d5-cddb93fde1e82020-12-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 317573
unii: JQT35NPK6C
PIOGLITAZONEPIOGLITAZONESolco Healthcare LLC1b77dbeb-61d1-4df3-872b-2f4f75a110db2020-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 312441
rxcui: 312440
rxcui: 317573

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.